ISSN: 2574-7800
Authors: Fawzy A and Oke Putranti I*
In the era where every national government promotes the quality of public health through family empowerment and national health insurance along with all its terms and arrangements, doctors as part of the public health service program are expected not mono-dimensional; dealing only the therapeutic elements of the health service, Doctors are expected to comprehend other factors, such as the availability and preparation form of the drug in the hospital formulary, and the efficacy of the patient's health costs. Propranolol is long known to be effective as a therapy for infantile haemangioma, and there are various propranolol therapy regimens for it. In theory, the oral administration of propranolol for infantile haemangioma ideally corresponds to the dose proposed by Léauté-Labréze which is 2 milligrams per kilogram body weight daily, in 6-hour intervals or 4 times of drug administration, and the patients are to have weekly evaluation for dose adjustment and assessment of side effects. In practice, modification to existing regimens to twice daily of 10 milligrams in order to accommodate adaptation to hospital formulary factors and the patient's socio-economic factors are proven to be practical, effective, yet still safe.
Keywords: Propranolol; Infantile Haemangioma; Practical Dose; Safe Dose; Drug Preparation; Cost Efficacy
